These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14521478)

  • 41. Schizophrenia and obesity: impact of antipsychotic medications.
    Wirshing DA
    J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacotherapy of first-episode psychosis.
    Lambert M; Conus P; Lambert T; McGorry PD
    Expert Opin Pharmacother; 2003 May; 4(5):717-50. PubMed ID: 12739997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Atypical antipsychotic-induced weight gain].
    Godlewska BR; Olajossy-Hilkesberger L; Marmurowska-Michałowska H; Olajossy M; Landowski J
    Psychiatr Pol; 2006; 40(5):995-1007. PubMed ID: 17217241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacogenetics of antipsychotic-induced weight gain.
    Müller DJ; Muglia P; Fortune T; Kennedy JL
    Pharmacol Res; 2004 Apr; 49(4):309-29. PubMed ID: 15202511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Practical Use of Pharmacotherapy for Obesity.
    Igel LI; Kumar RB; Saunders KH; Aronne LJ
    Gastroenterology; 2017 May; 152(7):1765-1779. PubMed ID: 28192104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation.
    Wehmeier PM; Gebhardt S; Schmidtke J; Remschmidt H; Hebebrand J; Theisen FM
    Psychiatry Res; 2005 Feb; 133(2-3):273-6. PubMed ID: 15741002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication: a review.
    Koponen H; Saari K; Savolainen M; Isohanni M
    Eur Arch Psychiatry Clin Neurosci; 2002 Dec; 252(6):294-8. PubMed ID: 12563538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The implications of weight changes with antipsychotic treatment.
    Sussman N
    J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antipsychotic-induced weight gain: a comprehensive research synthesis.
    Allison DB; Mentore JL; Heo M; Chandler LP; Cappelleri JC; Infante MC; Weiden PJ
    Am J Psychiatry; 1999 Nov; 156(11):1686-96. PubMed ID: 10553730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic consequences of atypical antipsychotic drugs.
    Lebovitz HE
    Psychiatr Q; 2003; 74(3):277-90. PubMed ID: 12918602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects of second-generation antipsychotics.
    Nwosu BU; Meltzer B; Maranda L; Ciccarelli C; Reynolds D; Curtis L; King J; Frazier JA; Lee MM
    J Pediatr Endocrinol Metab; 2011; 24(9-10):619-26. PubMed ID: 22145446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug-induced hyperphagia: what can we learn from psychiatric medications?
    Jensen GL
    JPEN J Parenter Enteral Nutr; 2008; 32(5):578-81. PubMed ID: 18753398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Weight gain and metabolic syndrome among young patients on antipsychotic medication: what do we know and where do we go?
    Eapen V; John G
    Australas Psychiatry; 2011 Jun; 19(3):232-5. PubMed ID: 21682621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do reductions in ghrelin contribute towards antipsychotic-induced weight gain?
    Firth J; Teasdale SB; Jackson SE; Vancampfort D; Siskind D; Sarris J; Solmi M
    Schizophr Res; 2019 Aug; 210():301-302. PubMed ID: 30595440
    [No Abstract]   [Full Text] [Related]  

  • 55. Abstinence, anticipation, reduction, and treatment (AART): a stepwise approach to the management of atypical antipsychotic side effects.
    Kennedy A; Tapp A; Kelly WS; Kilzieh N; Wood AE
    Essent Psychopharmacol; 2006; 7(1):1-14. PubMed ID: 16989288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A review of the effect of atypical antipsychotics on weight.
    Nasrallah H
    Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():83-96. PubMed ID: 12504074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic syndrome with the atypical antipsychotics.
    Pramyothin P; Khaodhiar L
    Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):460-6. PubMed ID: 20717020
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis.
    de Silva VA; Suraweera C; Ratnatunga SS; Dayabandara M; Wanniarachchi N; Hanwella R
    BMC Psychiatry; 2016 Oct; 16(1):341. PubMed ID: 27716110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychosis and delirium following metabolife use.
    Verduin ML; Labbate LA
    Psychopharmacol Bull; 2002; 36(3):42-5. PubMed ID: 12473963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychiatric medication-induced obesity: a review.
    Schwartz TL; Nihalani N; Jindal S; Virk S; Jones N
    Obes Rev; 2004 May; 5(2):115-21. PubMed ID: 15086865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.